AbZelect™ and AbZelectPRO™ cell line development platformsAbzena AbZelect™ and AbZelectPRO™ support cell line development (CLD) to rapidly progress therapeutic protein and recombinant vaccine projects while de-risking the journey to Investigational New Drug (IND) application. 0.0/5.0|0 ReviewsRequest PricingSelect product
ThioBridge™ next-generation conjugation technologyAbzena ThioBridge™ conjugation technology has been proven to enhance ADC development by overcoming issues with existing technologies in order to improve stability, potency, and efficacy. 0.0/5.0|0 ReviewsRequest PricingSelect product
EpiScreen® - Enhanced immunogencity assessement solutionAbzena EpiScreen® – an extensive suite of bioinformatic and primary human cell-based assays for immunogenicity assessment to inform of potential safety and efficacy risks in the clinic. 0.0/5.0|0 ReviewsRequest PricingSelect product
